IN SB0282

Establishes new requirements for drug compounding in Indiana, effective July 1, 2026, requiring bulk drug substances to be manufactured by FDA-registered facilities, accompanied by certificates of analysis, and prohibiting use of research-grade or veterinary-grade substances for human compounding.

Creates a mandatory registration system for medical spas beginning January 1, 2027, defining them as facilities offering cosmetic or lifestyle treatments (weight loss, wellness, botox, hormone therapies, etc.) that use prescription drugs for injection-based delivery.

Requires medical spas to designate a licensed responsible practitioner with prescriptive authority who must be physically present sufficient time to ensure compliance and verify all staff are properly licensed and trained.

Mandates medical spas report serious adverse events to the Medical Licensing Board within 15 days and authorizes fines up to $5,000 for operating without registration.

Requires the State Department of Health and Indiana Board of Pharmacy to publish biannual reports on drug compounding oversight, including data on licensed facilities, investigations conducted, and disciplinary actions taken.